Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19

The COVID-19 pandemic needs no introduction at present. Only a few treatments are available for this disease, including remdesivir and favipiravir. Accordingly, the pharmaceutical industry is striving to develop new treatments for COVID-19. Molnupiravir, an orally active RdRp inhibitor, is in a phas...

Descripción completa

Detalles Bibliográficos
Autores principales: Imran, Mohd., Kumar Arora, Mandeep, Asdaq, Syed Mohammed Basheeruddin, Khan, Shah Alam, Alaqel, Saleh I., Alshammari, Mohammed Kanan, Alshehri, Mohammed M., Alshrari, Ahmed Subeh, Mateq Ali, Alreshidi, Al-shammeri, Ahmed Muteb, Alhazmi, Bushra Dhuhayyan, Harshan, Aishah Ali, Alam, Md. Tauquir, , Abida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510125/
https://www.ncbi.nlm.nih.gov/pubmed/34641339
http://dx.doi.org/10.3390/molecules26195795

Ejemplares similares

Ejemplares similares